Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nanomaterials (Basel, Switzerland)|April 13, 2026
Lutetium-177 Radiolabeled Gold Nanoparticles for Prostate Cancer TheranosticsAdamantia Apostolopoulou, Evangelia-Alexandra Salvanou, Christos Liolios, et al.
Nanomaterials (Basel, Switzerland)|December 24, 2021
Biodistribution of Mesoporous Carbon Nanoparticles via Technetium-99m Radiolabelling after Oral Administration to MiceMaria Mamai, Dimitra Giasafaki, Evangelia-Alexandra Salvanou, et al.
Molecular Pharmaceutics|August 22, 2023
Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold NanoparticlesKinga Żelechowska-Matysiak, Evangelia-Alexandra Salvanou, Penelope Bouziotis, et al.
International Journal of Molecular Sciences|May 27, 2023
Old Drug, New Delivery Strategy: MMAE RepackagedHanane Lahnif, Tilmann Grus, Evangelia-Alexandra Salvanou, et al.
Frontiers in Nuclear Medicine|October 9, 2024
Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancerDanae Efremia Bajwa, Evangelia-Alexandra Salvanou, Maria Theodosiou, et al.
International Journal of Pharmaceutics|July 12, 2022
Synthesis and in vitro proof-of-concept studies on bispecific iron oxide magnetic nanoparticles targeting PSMA and GRP receptors for PET/MR imaging of prostate cancerChristos Liolios, Theodora S Koutsikou, Evangelia-Alexandra Salvanou, et al.
Molecules (Basel, Switzerland)|March 13, 2024
177Lu-Labeled Iron Oxide Nanoparticles Functionalized with Doxorubicin and Bevacizumab as Nanobrachytherapy Agents against Breast CancerEvangelia-Alexandra Salvanou, Argiris Kolokithas-Ntoukas, Danai Prokopiou, et al.
Nanomaterials (Basel, Switzerland)|July 27, 2022
Preliminary Evaluation of Iron Oxide Nanoparticles Radiolabeled with 68Ga and 177Lu as Potential Theranostic AgentsEvangelia-Alexandra Salvanou, Argiris Kolokithas-Ntoukas, Christos Liolios, et al.
Materials (Basel, Switzerland)|January 25, 2025
161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast CancerEvangelia-Alexandra Salvanou, Adamantia Apostolopoulou, Stavros Xanthopoulos, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate CancerChristos Liolios, Danai Bouziotis, Wiebke Sihver, et al.
Pageof 2